# FDA Inspection 983486 - American National Red Cross - May 13, 2016

Source: https://www.keypedia.com/records/fda_inspections/american-national-red-cross/c5b19e25-e072-4692-85dc-bd64b86c06be
Source feed: FDA_Inspections

> FDA Inspection 983486 for American National Red Cross on May 13, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 983486
- Company Name: American National Red Cross
- Inspection Date: 2016-05-13
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1223553 - 2023-11-03](https://www.keypedia.com/records/fda_inspections/american-national-red-cross/10b93a03-bce5-4f60-8d24-7479566095ca)
- [FDA Inspection 1083435 - 2019-03-08](https://www.keypedia.com/records/fda_inspections/american-national-red-cross/02f1a8f3-9561-497f-9f6e-9d9a790649cc)
- [FDA Inspection 888866 - 2014-07-25](https://www.keypedia.com/records/fda_inspections/american-national-red-cross/fefa344a-3e23-46f8-939c-3fa5fbf4d061)
- [FDA Inspection 798101 - 2012-09-10](https://www.keypedia.com/records/fda_inspections/american-national-red-cross/54683da6-e6c8-490e-a096-b0eb61f909a3)
- [FDA Inspection 650467 - 2010-03-08](https://www.keypedia.com/records/fda_inspections/american-national-red-cross/b363e6e5-85f2-4a47-8027-bdce67517bfe)

Company: https://www.keypedia.com/companies/american-national-red-cross/22d516f6-661e-429f-b954-23eef40a243d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
